Content about DSN AM

BENICIA, Calif. — CytoSport on Tuesday launched Evolve, a naturally flavored protein shake that will serve as a complement to any woman's evolution toward a healthy lifestyle. Shaped by Muscle Milk, Evolve is the latest protein beverage innovation to hit CytoSport's portfolio. Available in early January 2013, Evolve can be found in the weight management or protein nutrition aisle at retailers nationwide.

VALLEY FORGE, Pa. — Good Neighbor Pharmacy on Monday announced the dates for ThoughtSpot 2013: July 24 to 27 at the MGM Grand in Las Vegas.

"ThoughtSpot 2013 is Good Neighbor Pharmacy’s premier conference to provide community pharmacists new opportunities to grow their business," stated Scott Robinson, group VP of GNP. "It is more than just a purchasing event or a place to get [continuing-education] credits; pharmacists and store owners learn from each other and take away best practices that they can implement immediately."

SPRINGFIELD, Ill. — H. D. Smith on Tuesday announced plans to secure majority ownership in Triplefin, a privately held reimbursement, patient assistance and pharmaceutical brand support services company headquartered in Cincinnati, Ohio. H. D. Smith will immediately obtain majority board vote, and by mid-2013, majority stock ownership.

HONG KONG — Hong Kong-based Li & Fung — a multinational consumer goods sourcing, distribution and logistics group — has acquired Lornamead for about $190 million.

LA JOLLA, Calif. — Kashi, the premier natural food and lifestyle company, today announced the expansion of its popular pita crisp line with the introduction of Kashi Garlic Pesto Pita Crisps, a tasty option for people looking for a savory snack that's both wholesome and delicious.

CHICAGO — Lifes2good Natural Healthcare recently announced the introduction of a pair of new hair growth supplements: Viviscal Extra Strength and Viviscal Man. 

The new extra-strength formulation contains 50% more of the active ingredient AminoMar, a proprietary blend of ingredients and proteins said to promote existing hair growth. It also contains new ingredients biotin, iron and zinc.  

SALT LAKE CITY — Zarbee's on Tuesday noted that more consumers have gravitated toward natural solutions over allopathic medicines, at least through the end of December, citing Nielsen scan data. 

For the 12 weeks ended Dec. 31, supplemental immune system boosters and homeopathic cough and cold medicines were up 13%, Zarbee's reported. The trend is even more pronounced across children's remedies with allopathic medicines declining 15% in the 12 week period while sales of pediatric natural solutions were up 19%, and now make up more than 20% of the category. 

NEW YORK — The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

According to The New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

NEW YORK — CVS/pharmacy has decided to stock Tylenol pain reliever in only half of its stores, according to a Reuters report published Monday. 

According to the report, CVS will stock Tylenol in each market, but not in each store as CVS seeks to plug any out-of-stock holes left behind by the initial recall of Tylenol three years ago and the brand's slow trek back to shelf. 

ATLANTA — SoloHealth on Monday announced its new pay-per-performance ad format called SoloTrigger. A permission-based advertising format, SoloTrigger delivers targeted and relevant sponsor content that allows consumers to actively request additional information regarding products or services that will help them live a healthier lifestyle, the company stated. 

NEW YORK — While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

The study, led by investigators at the Massachusetts General Hospital and Weill Cornell Medical College, and published in the Jan. 15 issue of Annals of Internal Medicine, found $1 billion in potential savings, but the more complicated treatment regimen might result in more patients missing doses and a loss of drug effectiveness.

LINCOLN, Calif. — A drug-security product has won a drug-abuse prevention award.

The Locking Cap was named as one of the "Top 5 Technologies to Reduce Prescription Drug Abuse" by the Center for Lawful Access and Abuse Deterrence.

The cap is a four-digit combination-locking lid for prescription medication bottles. The maker of the cap, Cap-n-Lock, launched an updated version of the cap at the beginning of the year to attract the attention of shoppers.